In summary, our research shows that miR-495-3p inhibits the progression of colorectal cancer by downregulating the expression of HMGB1 in vivo and in vitro, which indicates that miR-495-3p may become a potential therapeutic target for colorectal cancer. The gene discussed is HMGB1; the disease is colorectal cancer.